Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lewis R Roberts

Showing results (251-260 of 393) with videos related to

Pageof 40
Sort By:
Gastrointestinal Endoscopy|December 6, 2021
Impact of trimodality sampling on detection of malignant biliary strictures compared with patients with primary sclerosing cholangitisSerge Baroud, Alexander J Sahakian, Tarek Sawas, et al.
Hepatology (Baltimore, Md.)|December 21, 2019
Endoscopic Ultrasound/Fine Needle Aspiration Is Effective for Lymph Node Staging in Patients With CholangiocarcinomaThomas Malikowski, Michael J Levy, Ferga C Gleeson, et al.
JHEP Reports : Innovation in Hepatology|November 24, 2025
Blood and tissue dysregulated bile acids and short-chain fatty acids in cholangiocarcinomaYaming Liu, Hind Hassan, Tayla R Brooks, et al.
Hepatology Communications|October 7, 2025
Performance of the multi-target hepatocellular carcinoma blood test: Design and rationale of the ALTUS studyBinu V John, Mark Camardo, Kyle Porter, et al.
Cell Reports|February 24, 2021
Targeting EphA2 suppresses hepatocellular carcinoma initiation and progression by dual inhibition of JAK1/STAT3 and AKT signalingHao Wang, Wei Hou, Aldeb Perera, et al.
American Journal of Epidemiology|May 20, 2017
Characteristics of US-Born Versus Foreign-Born Americans of African Descent With Chronic Hepatitis BMohamed A Hassan, W Ray Kim, Ruosha Li, et al.
Hepatology (Baltimore, Md.)|February 29, 2012
Model to estimate survival in ambulatory patients with hepatocellular carcinomaJu Dong Yang, W Ray Kim, Kyung Woo Park, et al.
Cell Reports|August 29, 2025
Targeting EphA2 suppresses hepatocellular carcinoma initiation and progression by dual inhibition of JAK1/STAT3 and AKT signalingHao Wang, Wei Hou, Aldeb Perera, et al.
Hepatology (Baltimore, Md.)|May 21, 2020
Trial Design and Endpoints in Hepatocellular Carcinoma: AASLD Consensus ConferenceJosep M Llovet, Augusto Villanueva, Jorge A Marrero, et al.
Gastroenterology|July 10, 2023
Incidence and Risk Factors for Hepatocellular Carcinoma in Cirrhosis: The Multicenter Hepatocellular Carcinoma Early Detection Strategy (HEDS) StudyK Rajender Reddy, Dale McLerran, Tracey Marsh, et al.
Pageof 40

Showing results (251-260 of 393) with videos related to

Sort By:
Pageof 40
Gastrointestinal Endoscopy|December 6, 2021
Impact of trimodality sampling on detection of malignant biliary strictures compared with patients with primary sclerosing cholangitisSerge Baroud, Alexander J Sahakian, Tarek Sawas, et al.
Hepatology (Baltimore, Md.)|December 21, 2019
Endoscopic Ultrasound/Fine Needle Aspiration Is Effective for Lymph Node Staging in Patients With CholangiocarcinomaThomas Malikowski, Michael J Levy, Ferga C Gleeson, et al.
JHEP Reports : Innovation in Hepatology|November 24, 2025
Blood and tissue dysregulated bile acids and short-chain fatty acids in cholangiocarcinomaYaming Liu, Hind Hassan, Tayla R Brooks, et al.
Hepatology Communications|October 7, 2025
Performance of the multi-target hepatocellular carcinoma blood test: Design and rationale of the ALTUS studyBinu V John, Mark Camardo, Kyle Porter, et al.
Cell Reports|February 24, 2021
Targeting EphA2 suppresses hepatocellular carcinoma initiation and progression by dual inhibition of JAK1/STAT3 and AKT signalingHao Wang, Wei Hou, Aldeb Perera, et al.
American Journal of Epidemiology|May 20, 2017
Characteristics of US-Born Versus Foreign-Born Americans of African Descent With Chronic Hepatitis BMohamed A Hassan, W Ray Kim, Ruosha Li, et al.
Hepatology (Baltimore, Md.)|February 29, 2012
Model to estimate survival in ambulatory patients with hepatocellular carcinomaJu Dong Yang, W Ray Kim, Kyung Woo Park, et al.
Cell Reports|August 29, 2025
Targeting EphA2 suppresses hepatocellular carcinoma initiation and progression by dual inhibition of JAK1/STAT3 and AKT signalingHao Wang, Wei Hou, Aldeb Perera, et al.
Hepatology (Baltimore, Md.)|May 21, 2020
Trial Design and Endpoints in Hepatocellular Carcinoma: AASLD Consensus ConferenceJosep M Llovet, Augusto Villanueva, Jorge A Marrero, et al.
Gastroenterology|July 10, 2023
Incidence and Risk Factors for Hepatocellular Carcinoma in Cirrhosis: The Multicenter Hepatocellular Carcinoma Early Detection Strategy (HEDS) StudyK Rajender Reddy, Dale McLerran, Tracey Marsh, et al.
Pageof 40